Frequently Asked Questions

Get answers to common questions about PT-141.

Many clients report increased sexual desire within hours to days after administration, though response times vary. We assess individual factors, adjust dosing as needed, and schedule follow-ups to monitor effectiveness and tailor the treatment plan.

PT-141 is non-hormonal; it targets melanocortin receptors in the nervous system to stimulate arousal. This makes it suitable for people seeking libido enhancement without altering hormone levels, under clinical supervision and individualized evaluation.

Common side effects are mild and short-lived, including flushing, nausea, headache, or transient changes in blood pressure. We review your medical history, start at conservative doses, and provide guidance to manage symptoms if they occur.

Duration varies by individual; a single PT-141 dose can produce effects lasting several hours. Treatment plans and dosing frequency are individualized based on response, goals, and tolerance during follow-up appointments.

Ideal candidates are adults experiencing decreased sexual desire who want a non-hormonal option. We evaluate medical history, medications, cardiovascular risk, and expectations to determine suitability and create a personalized, safe treatment strategy.

PT-141 can often be combined safely with certain therapies, but interactions and risks depend on medications and health conditions. Our clinicians review your full health profile and coordinate complementary approaches to maximize benefits while minimizing adverse effects.

fbq('track', 'Schedule')